Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03400176 |
| Title | VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Diego - Moores Cancer Center | La Jolla | California | 92093-0658 | United States | Details | |
| David Geffen School of Medicine at UCLA David Geffen School of Med | Los Angeles | California | 90095 | United States | Details | |
| Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
| Tennessee Oncology Centennial Medical Center | Nashville | Tennessee | 37203 | United States | Details | |
| University of Utah / Huntsman Cancer Institute Oncology | Salt Lake City | Utah | 84103 | United States | Details |